Resmed announced today that it began a comprehensive brand evolution to unify its brand portfolio. The company aims to serve more people and healthcare providers worldwide and reflect growing direct-to-consumer engagement. San Diego-based Resmed, a leader in respiratory therapy — including CPAP therapy for sleep apnea — also offers digital health solutions. Its last brand […]
ResMed Inc.
ResMed stock ticks up on Street-beating Q1
ResMed (NYSE:RMD) shares are on the rise today on first-quarter results that came in ahead of the consensus forecast on Wall Street. Shares of RMD ticked up 4.4% to $249.51 apiece in pre-market trading today. The San Diego–based sleep respiratory technology company reported profits of $311.4 million. That equals $2.11 per share on sales of […]
ResMed launches new patient-centric digital solutions for sleep apnea
ResMed today announced new patient-centric products designed to enhance therapy for sleep apnea patients. The new innovations from the sleep apnea therapy maker integrate with digital wearable devices and generative AI. San Diego-based ResMed said they aim to provide a more personalized sleep health experience while improving overall health. The company cited a recent survey […]
ResMed launches new sleep apnea mask with tube-up design
ResMed announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask. San Diego-based ResMed designed the new mask to create a natural and comfortable sleep experience for users with sleep apnea. It features a fabric-wrapped frame and a soft, breathable, moisture-wicking design for optimal comfort in a tube-up design. The […]
BD’s CFO joins the board at ResMed
ResMed announced today that it expanded the size of its board of directors with the appointment of Christopher DelOrefice. The addition of DelOrefice, who serves as CFO at BD, expands the ResMed board to 11 total directors. His appointment goes into effect immediately, and he will stand for re-election with the rest of the board […]
ResMed studies show PAP therapy leads to less hospitalizations
ResMed today announced data from a number of clinical studies demonstrating the benefits of its positive airway pressure (PAP) therapy. San Diego-based ResMed presented 13 new studies highlighting the use of PAP therapy for obstructive sleep apnea (OSA) at SLEEP 2024. One study looked at adherence to PAP therapy and its link to hospital visits […]
ResMed sees increased sleep device demand, stock rises on Q3 beats
ResMed shares ticked up after hours on third-quarter results that came in ahead of the consensus forecast. Shares of RMD rose more than 4% to $191 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished the day down 1%. The San […]
Analysts remain high on ResMed despite potential sleep apnea benefits from GLP-1s
William Blair analysts say that new data supporting the use of GLP-1s in patients with sleep apnea shouldn’t displace companies like ResMed in the market. GLP-1 receptor agonists, like Ozempic and Wegovy, provide therapy for diabetes and can lead to weight loss. Beyond impacting the diabetes industry, questions have arisen over their overall impact on […]
ResMed launches new sleep apnea mask
ResMed announced today that it launched the AirFit F40 ultra-compact, full-face mask for sleep apnea. San Diego-based ResMed designed AirFit F40 to offer the comfort of smaller masks without sacrificing performance. This could, in turn, help with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment. According to a news […]
ResMed hits supply chain constraints as it responds to major Philips recall
ResMed (NYSE: RMD) saw a dramatic surge in demand for its sleep and respiratory care products after a serious recall knocked competitor Philips out of the market for a year, according to CEO Mick Farrell. But Farrell also explained during ResMed’s Q4 earnings call yesterday evening that the San Diego–based company is running into supply […]
These medtech stocks performed the best in 2020
While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while […]
